Sabra Healthcare REIT, Inc. $SBRA Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System reduced its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 9.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 294,008 shares of the real estate investment trust’s stock after selling 30,704 shares during the period. New York State Teachers Retirement System owned 0.12% of Sabra Healthcare REIT worth $5,654,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. raised its stake in Sabra Healthcare REIT by 1.4% during the 4th quarter. Vanguard Group Inc. now owns 35,430,016 shares of the real estate investment trust’s stock worth $671,045,000 after acquiring an additional 481,231 shares in the last quarter. Principal Financial Group Inc. grew its holdings in shares of Sabra Healthcare REIT by 21.6% during the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after purchasing an additional 4,431,897 shares during the last quarter. Nuveen LLC grew its holdings in shares of Sabra Healthcare REIT by 28.6% during the fourth quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock worth $138,324,000 after purchasing an additional 1,625,072 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Sabra Healthcare REIT by 2.9% during the fourth quarter. Geode Capital Management LLC now owns 7,018,556 shares of the real estate investment trust’s stock worth $132,949,000 after purchasing an additional 198,118 shares in the last quarter. Finally, Bank of America Corp DE lifted its holdings in shares of Sabra Healthcare REIT by 9.4% in the 3rd quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock valued at $97,378,000 after purchasing an additional 447,528 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Up 1.7%

NASDAQ:SBRA opened at $20.06 on Wednesday. The firm has a market cap of $5.06 billion, a P/E ratio of 31.84, a PEG ratio of 1.47 and a beta of 0.65. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The stock’s 50 day simple moving average is $19.70 and its 200-day simple moving average is $19.68. Sabra Healthcare REIT, Inc. has a 12-month low of $17.17 and a 12-month high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, hitting the consensus estimate of $0.16. The firm had revenue of $211.74 million during the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The company’s revenue for the quarter was up 20.9% on a year-over-year basis. During the same period last year, the company earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.0%. Sabra Healthcare REIT’s payout ratio is presently 190.48%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. Cantor Fitzgerald raised their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Monday, May 11th. Raymond James Financial started coverage on Sabra Healthcare REIT in a research note on Wednesday, June 17th. They issued an “underperform” rating for the company. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Weiss Ratings cut shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 4th. Finally, UBS Group set a $19.00 price target on shares of Sabra Healthcare REIT in a research report on Thursday, June 18th. Five analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Sabra Healthcare REIT presently has a consensus rating of “Hold” and a consensus target price of $21.27.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.